04/30/2024
4:26 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
3:46 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 10-K/A | |
04/19/2024
4:10 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
9:08 AM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 424B5 | |
04/18/2024
7:21 AM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 424B5 | |
04/15/2024
4:22 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
4:13 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 424B3 | |
|
04/15/2024
5:00 AM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 424B3 | |
04/02/2024
5:01 AM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
4:18 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/21/2024
4:09 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
4:08 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form DEFA14A | |
03/11/2024
4:16 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form DEF 14A | |
02/28/2024
4:09 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
9:40 AM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 424B5 | |
02/26/2024
4:15 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 424B5 | |
02/14/2024
5:03 AM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
3:37 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2024
3:16 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2024
5:36 PM | NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
Rehnquist Janet (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
3:30 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form PRE 14A | |
12/29/2023
3:15 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2023
3:30 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K/A | |
11/22/2023
3:31 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form DEF 14A | |
11/22/2023
3:32 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form ARS | |
11/21/2023
4:23 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2023
3:05 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2023
3:04 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2023
8:19 AM | Gorovitz Aaron (Reporting)
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
8:15 AM | Hurvitz Chaim (Reporting)
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
3:48 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/31/2023
4:18 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 424B3 | |
08/31/2023
4:20 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2023
11:14 AM | Javitt Jonathan C (Reporting)
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2023
8:24 AM | Javitt Jonathan C (Reporting)
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
4:10 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/28/2023
4:15 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/08/2023
9:21 AM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 424B5 | |
06/07/2023
4:18 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K/A | |
06/06/2023
3:27 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2023
7:00 AM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks.
It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives.
But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars.
And here's the good news. Register For The Webinar To Discover |
